Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01910623
What this trial is testing

Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Post-approval studies (Phase 4)UnknownNCT03026842
What this trial is testing

Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)

Who this might be right for
Acute Myeloid Leukemia
The First Hospital of Jilin University 180
Not applicableStudy completedNCT03435341
What this trial is testing

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 151
Testing effectiveness (Phase 2)Ended earlyNCT01794169
What this trial is testing

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Karolinska University Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01664897
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+8 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT04964518
What this trial is testing

APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
AML, Adult
Ascentage Pharma Group Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT00961142
What this trial is testing

Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
University Hospital Tuebingen 23
Not applicableActive Not RecruitingNCT04482894
What this trial is testing

Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS

Who this might be right for
Leukemia, AcuteAML, AdultALL, Adult+1 more
University of Virginia 105
Testing effectiveness (Phase 2)Looking for participantsNCT01409161
What this trial is testing

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center 151
Not applicableActive Not RecruitingNCT07458542
What this trial is testing

Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Bristol-Myers Squibb 44
Not applicableLooking for participantsNCT06256627
What this trial is testing

The Maintenance Treatment of "ITIVA" in AML Patients

Who this might be right for
Acute Myeloid LeukemiaMaintenance TreatmentMinor Residue Disease+5 more
Henan Cancer Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT00268242
What this trial is testing

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03897127
What this trial is testing

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 882
Not applicableStudy completedNCT00897559
What this trial is testing

Study of Bone Marrow Samples From Patients With Acute Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 40
Early research (Phase 1)Looking for participantsNCT06498973
What this trial is testing

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 43
Testing effectiveness (Phase 2)UnknownNCT03181815
What this trial is testing

Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse Leukemia
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Study completedNCT01667133
What this trial is testing

Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Ariad Pharmaceuticals 35
Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Testing effectiveness (Phase 2)UnknownNCT02856464
What this trial is testing

Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
King's College Hospital NHS Trust 124
Next Page